Riskpilot← Back to searchSign inGet full accessSAGEN BOLIG AS
ASActiveOrg 932039400Kontorveien 15, 4033 StavangerDevelopment of building projects · NACE 6812Est. 20231 employees
Revenue 2025
NOK 1M
+8% vs 2024
EBITDA margin
-173.1%
-16% vs 2024
Equity ratio
28.1%
Financial strength
Net profit 2025
NOK 2,4M
+481% vs 2024
| Revenue | NOK 1M | +8% |
| EBITDA | NOK -1,8M | -16% |
| Net profit | NOK 2,4M | +481% |
| Total assets | NOK 32,8M | +32% |
| Equity | NOK 9,2M | +36% |
| Employees | 1 | — |
Legal name
SAGEN BOLIG AS
Org number
932039400
Legal form
Aksjeselskap
NACE code
6812 · Development of building projects
Founded
7. september 2023
Share capital
NOK 600 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene. Daglig leder alene.
Company purpose
Kjøpe tomteområder, utvikle, selge og bygge ut i regi av byggmester sagen as.
Address
Kontorveien 15, 4033 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 95 | 956 | 1 028 |
| Staff expenses | −662 | −1 695 | −1 905 |
| EBITDA | −777 | −1 529 | −1 780 |
| Depreciation & amort. | −0 | −7 | −43 |
| EBIT | −777 | −1 536 | −1 822 |
| Net financials | −0 | 928 | 4 968 |
| Profit before tax | −777 | −608 | 3 145 |
| Tax | −169 | 32 | 704 |
| Net profit | −609 | −640 | 2 441 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 28 671 | 24 863 | 32 828 |
| Equity | −579 | 6 781 | 9 222 |
| Long-term debt | 15 418 | 17 478 | 19 707 |
| Short-term debt | 13 832 | 604 | 3 898 |
| Total debt | 29 250 | 18 082 | 23 605 |
EBITDA margin
-173.1%
This company
15.8%
Market median
-1196% vs market
20232025
Equity ratio
28.1%
This company
38.2%
Market median
-26% vs market
20232025
Return on equity
26.5%
This company
18.4%
Market median
+44% vs market
20232025
Net profit margin
237.4%
This company
8.1%
Market median
+2831% vs market
20232025
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20232025
Debt / equity
2.56×
This company
0.62×
Market median
-313% vs market
20232025
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ØK Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Board of Directors | 2024 | |
| Board of Directors | 2023 | |
| Board of Directors | 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SAGEN BOLIG AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Øyvind Kvinlog Brakstad | Chief Executive Officer | 0 companies |
| Christoffer Myhre | Board of Directors | 0 companies |
| Kjell Rommetvedt | Chairman | 0 companies |
| Arne Incoronato | Board of Directors | 0 companies |
| Jo Frøyen | Board of Directors | 0 companies |
| Per Andre Rykhus | Board of Directors | 0 companies |